Verifying and Validating Quantitative Systems Pharmacology and In Silico Models in Drug Development: Current Needs, Gaps, and Challenges

被引：19

作者：

Musuamba, Flora T. ^{[1
,2
,3
]}

Bursi, Roberta ^{[4
]}

Manolis, Efthymios ^{[1
,5
]}

Karlsson, Kristin ^{[1
,6
]}

Kulesza, Alexander ^{[7
]}

Courcelles, Eulalie ^{[7
]}

Boissel, Jean-Pierre ^{[7
]}

Lesage, Raphaelle ^{[8
]}

Crozatier, Cecile ^{[9
]}

Voisin, Emmanuelle M. ^{[9
]}

Rousseau, Cecile F. ^{[9
]}

Marchal, Thierry ^{[10
]}

Alessandrello, Rossana ^{[11
]}

Geris, Liesbet ^{[8
,12
]}

机构：

[1] EMA Modelling & Simulat Working Party, Amsterdam, Netherlands

[2] Fed Agcy Med & Hlth Prod, Brussels, Belgium

[3] Univ Lubumbashi, Fac Sci Pharmaceut, Lubumbashi, DEM REP CONGO

[4] InSilicoTrials Technol, Milan, Italy

[5] European Med Agcy, Amsterdam, Netherlands

[6] Med Prod Agcy, Uppsala, Sweden

[7] Novadiscovery, Lyon, France

[8] Katholieke Univ Leuven, Leuven, Belgium

[9] Voisin Consulting Life Sci, Paris, France

[10] Ansys, Wavre, Belgium

[11] AQuAS Agcy Hlth Qual & Assessment Catalonia, Catalonia, Spain

[12] Univ Liege, Liege, Belgium

来源：

CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY | 2020年 / 9卷 / 04期

关键词：

D O I：

10.1002/psp4.12504

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：195 / 197

页数：3

共 50 条

[21] Integration not isolation: arguing the case for quantitative and systems pharmacology in drug discovery and development
Agoram, Balaji M.
Demin, Oleg
DRUG DISCOVERY TODAY, 2011, 16 (23-24) : 1031 - 1036
[22] Applying quantitative and systems pharmacology to drug development and beyond: An introduction to clinical pharmacologists
Ramasubbu, Mathan Kumar
Paleja, Bhairav
Srinivasann, Anand
Maiti, Rituparna
Kumar, Rukmini
INDIAN JOURNAL OF PHARMACOLOGY, 2024, 56 (04) : 268 - 276
[23] USING QUANTITATIVE SYSTEMS PHARMACOLOGY (QSP) MODELS TO CHARACTERIZE THE PK OF NOVEL DRUG MODALITIES
Nobisch, Jamie
DRUG METABOLISM AND PHARMACOKINETICS, 2024, 55
[24] Challenges of Psychiatry Drug Development and the Role of Human Pharmacology Models in Early Development-A Drug Developer's Perspective
Zhu, Tong
FRONTIERS IN PSYCHIATRY, 2021, 11
[25] Development of and insights from systems pharmacology models of antibody-drug conjugates
Lam, Inez
Reddy, Venkatesh Pilla
Ball, Kathryn
Arends, Rosalinda H.
Mac Gabhann, Feilim
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2022, 11 (08): : 967 - 990
[26] Quantitative systems pharmacology approaches to increase confidence in rationale for drug discovery and development programs
Musante, Cynthia J.
Allen, Richard
Rieger, Theodore R.
Thompson, W. Clayton
DRUG METABOLISM REVIEWS, 2016, 48 : 11 - 11
[27] Applications of Quantitative Systems Pharmacology (QSP) in Drug Development for NAFLD and NASH and Its Regulatory Application
Siler, Scott Q.
PHARMACEUTICAL RESEARCH, 2022, 39 (08) : 1789 - 1802
[28] Computational neurosciences and quantitative systems pharmacology: a powerful combination for supporting drug development in neurodegenerative diseases
Geerts, Hugo
Bergeler, Silke
Lytton, William W.
van der Graaf, Piet H.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2024, 51 (05) : 563 - 573
[29] Next-Generation Model-Based Drug Discovery and Development: Quantitative and Systems Pharmacology
Allerheiligen, S. R. B.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 88 (01) : 135 - 137
[30] Applications of Quantitative Systems Pharmacology (QSP) in Drug Development for NAFLD and NASH and Its Regulatory Application
Scott Q. Siler
Pharmaceutical Research, 2022, 39 : 1789 - 1802

← 1 2 3 4 5 →